<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0223017.ref054">
 <label>54</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Luo</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Vasudevan</surname>
   <given-names>SG</given-names>
  </name>, 
  <name>
   <surname>Lescar</surname>
   <given-names>J</given-names>
  </name>. 
  <article-title>The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development</article-title>. 
  <source>Antiviral Res</source>. 
  <year>2015</year>;
  <volume>118</volume>:
  <fpage>148</fpage>â€“
  <lpage>58</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.03.014</pub-id> .
  <?supplied-pmid 25842996?>
  <pub-id pub-id-type="pmid">25842996</pub-id>
 </mixed-citation>
</ref>
